[go: up one dir, main page]

FI20075417A0 - Koostumuksia ja menetelmiä alkion kantasolujen kasvatukseen - Google Patents

Koostumuksia ja menetelmiä alkion kantasolujen kasvatukseen

Info

Publication number
FI20075417A0
FI20075417A0 FI20075417A FI20075417A FI20075417A0 FI 20075417 A0 FI20075417 A0 FI 20075417A0 FI 20075417 A FI20075417 A FI 20075417A FI 20075417 A FI20075417 A FI 20075417A FI 20075417 A0 FI20075417 A0 FI 20075417A0
Authority
FI
Finland
Prior art keywords
formulations
methods
stem cells
embryonic stem
culturing embryonic
Prior art date
Application number
FI20075417A
Other languages
English (en)
Swedish (sv)
Inventor
Marjo-Riitta Suuronen
Kristiina Rajala
Outi Hovatta
Heli Skottman
Original Assignee
Marjo-Riitta Suuronen
Kristiina Rajala
Outi Hovatta
Heli Skottman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marjo-Riitta Suuronen, Kristiina Rajala, Outi Hovatta, Heli Skottman filed Critical Marjo-Riitta Suuronen
Priority to FI20075417A priority Critical patent/FI20075417A0/fi
Publication of FI20075417A0 publication Critical patent/FI20075417A0/fi
Priority to AU2008259726A priority patent/AU2008259726A1/en
Priority to CA002689321A priority patent/CA2689321A1/en
Priority to KR1020107000131A priority patent/KR20100025569A/ko
Priority to EP08761727A priority patent/EP2155859A4/en
Priority to JP2010510839A priority patent/JP2010528642A/ja
Priority to PCT/FI2008/050331 priority patent/WO2008148938A1/en
Priority to US12/632,057 priority patent/US20100081200A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI20075417A 2007-06-05 2007-06-05 Koostumuksia ja menetelmiä alkion kantasolujen kasvatukseen FI20075417A0 (fi)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FI20075417A FI20075417A0 (fi) 2007-06-05 2007-06-05 Koostumuksia ja menetelmiä alkion kantasolujen kasvatukseen
AU2008259726A AU2008259726A1 (en) 2007-06-05 2008-06-04 Formulations and methods for culturing embryonic stem cells
CA002689321A CA2689321A1 (en) 2007-06-05 2008-06-04 Formulations and methods for culturing embryonic stem cells
KR1020107000131A KR20100025569A (ko) 2007-06-05 2008-06-04 배아 줄기 세포 배양을 위한 제형 및 방법
EP08761727A EP2155859A4 (en) 2007-06-05 2008-06-04 FORMULATIONS AND METHODS FOR CULTIVATING EMBRYONIC STEM CELLS
JP2010510839A JP2010528642A (ja) 2007-06-05 2008-06-04 胚幹細胞の培養処方および方法
PCT/FI2008/050331 WO2008148938A1 (en) 2007-06-05 2008-06-04 Formulations and methods for culturing embryonic stem cells
US12/632,057 US20100081200A1 (en) 2007-06-05 2009-12-07 Formulations and methods for culturing stem cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20075417A FI20075417A0 (fi) 2007-06-05 2007-06-05 Koostumuksia ja menetelmiä alkion kantasolujen kasvatukseen

Publications (1)

Publication Number Publication Date
FI20075417A0 true FI20075417A0 (fi) 2007-06-05

Family

ID=38212388

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20075417A FI20075417A0 (fi) 2007-06-05 2007-06-05 Koostumuksia ja menetelmiä alkion kantasolujen kasvatukseen

Country Status (8)

Country Link
US (1) US20100081200A1 (fi)
EP (1) EP2155859A4 (fi)
JP (1) JP2010528642A (fi)
KR (1) KR20100025569A (fi)
AU (1) AU2008259726A1 (fi)
CA (1) CA2689321A1 (fi)
FI (1) FI20075417A0 (fi)
WO (1) WO2008148938A1 (fi)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20030376A1 (it) 2003-07-31 2005-02-01 Univ Roma Procedimento per l'isolamento e l'espansione di cellule staminali cardiache da biopsia.
US11660317B2 (en) 2004-11-08 2023-05-30 The Johns Hopkins University Compositions comprising cardiosphere-derived cells for use in cell therapy
US8871752B2 (en) * 2008-02-19 2014-10-28 Sucampo Ag Method for modulating stem cell growth
CN102762718B (zh) * 2009-10-13 2015-06-17 干细胞技术公司 用于分化干细胞的重量克分子渗透压浓度控制
US9708582B2 (en) 2009-10-13 2017-07-18 Stemcell Technologies Inc. Method of differentiating stem cells
ES2779048T3 (es) * 2009-11-12 2020-08-13 Technion Res & Dev Foundation Medios de cultivo, cultivos celulares y métodos de cultivo de células madre pluripotentes en un estado indiferenciado
FI20096288A0 (fi) * 2009-12-04 2009-12-04 Kristiina Rajala Formulations and methods for culturing stem cells
KR101169701B1 (ko) * 2010-02-26 2012-07-30 (주) 아크스템 자하거 추출물을 함유하는 세포보존제
US9249392B2 (en) * 2010-04-30 2016-02-02 Cedars-Sinai Medical Center Methods and compositions for maintaining genomic stability in cultured stem cells
US9845457B2 (en) 2010-04-30 2017-12-19 Cedars-Sinai Medical Center Maintenance of genomic stability in cultured stem cells
WO2012103098A2 (en) * 2011-01-24 2012-08-02 Immunepath, Inc. Compositions and methods for treating hematological cytopenias
WO2013019661A1 (en) 2011-07-29 2013-02-07 Cellular Dynamics International, Inc. Metabolic maturation in stem cell-derived tissue cells
US9314506B2 (en) 2011-10-24 2016-04-19 Research Development Foundation Methods for increasing insulin secretion by co-stimulation of corticotropin-releasing factor receptors
WO2013184527A1 (en) 2012-06-05 2013-12-12 Capricor, Inc. Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy
DE102012213838A1 (de) * 2012-08-03 2014-02-06 Katharina Pachmann Verfahren zur Kultivierung einer Subpopulation zirkulierender epithelialer Tumorzellen aus einer Körperflüssigkeit
JP6433896B2 (ja) 2012-08-13 2018-12-05 シーダーズ−サイナイ・メディカル・センターＣｅｄａｒｓ−Ｓｉｎａｉ Ｍｅｄｉｃａｌ Ｃｅｎｔｅｒ 組織再生のためのエキソソームおよびマイクロリボ核酸
US9540613B2 (en) * 2013-04-29 2017-01-10 Wisconsin Alumni Research Foundation Methods for producing insulin-secreting beta cells from human pluripotent stem cells
JP6529486B2 (ja) 2013-06-05 2019-06-12 バイオタイム インク．Ｂｉｏｔｉｍｅ Ｉｎｃ． 哺乳動物種における誘導組織再生のための組成物および方法
US11078462B2 (en) 2014-02-18 2021-08-03 ReCyte Therapeutics, Inc. Perivascular stromal cells from primate pluripotent stem cells
US10240127B2 (en) 2014-07-03 2019-03-26 ReCyte Therapeutics, Inc. Exosomes from clonal progenitor cells
JP6878274B2 (ja) 2014-10-03 2021-05-26 シーダーズ−サイナイ・メディカル・センターＣｅｄａｒｓ−Ｓｉｎａｉ Ｍｅｄｉｃａｌ Ｃｅｎｔｅｒ 筋ジストロフィーの処置における心筋球由来細胞およびこのような細胞によって分泌されたエキソソーム
US10384207B2 (en) 2015-07-21 2019-08-20 Neuro Probe Incorporated Assay apparatus and methods
WO2017100313A1 (en) 2015-12-07 2017-06-15 Biotime, Inc. Methods for the re-derivation of diverse pluripotent stem cell-derive brown fat cells
WO2017123662A1 (en) 2016-01-11 2017-07-20 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
WO2017210652A1 (en) 2016-06-03 2017-12-07 Cedars-Sinai Medical Center Cdc-derived exosomes for treatment of ventricular tachyarrythmias
EP3515459A4 (en) 2016-09-20 2020-08-05 Cedars-Sinai Medical Center CELLS DERIVED FROM CARDIOSPHERES AND THEIR EXTRACELLULAR VESICLES TO DELAY OR REVERSE AGING AND AGE-RELATED DISORDERS
CA3059910A1 (en) 2017-04-19 2018-10-25 Cedars-Sinai Medical Center Methods and compositions for treating skeletal muscular dystrophy
EP3727351A4 (en) 2017-12-20 2021-10-06 Cedars-Sinai Medical Center MANIPULATED EXTRACELLULAR VESICLES FOR ENHANCED RELEASE INTO TISSUE
WO2019152549A1 (en) 2018-02-05 2019-08-08 Cedars-Sinai Medical Center Methods for therapeutic use of exosomes and y-rnas
CN111944752B (zh) * 2020-08-28 2021-09-03 广州同康生物科技有限公司 骨骼肌干细胞无血清培养基及其制备方法
US11164014B1 (en) 2020-11-09 2021-11-02 Hayden Ai Technologies, Inc. Lane violation detection using convolutional neural networks
US11322017B1 (en) 2021-01-28 2022-05-03 Hayden Ai Technologies, Inc. Systems and methods for managing traffic rules using multiple mapping layers with traffic management semantics
US12333821B2 (en) 2021-04-28 2025-06-17 Hayden Ai Technologies, Inc. Systems and methods for enforcing traffic congestion pricing
JPWO2023286772A1 (fi) * 2021-07-12 2023-01-19
WO2023014712A1 (en) * 2021-08-02 2023-02-09 Montana State University Chemically defined serum replacements for cell culture
KR102817880B1 (ko) * 2021-11-17 2025-06-10 주식회사 웰진 무혈청 세포 배양 배지 조성물 및 이의 용도
KR102817881B1 (ko) * 2021-11-17 2025-06-10 주식회사 웰진 저혈청 배지 첨가제 및 이의 용도
US11776276B1 (en) 2022-11-14 2023-10-03 Hayden Al Technologies, Inc. System and methods for automatically validating evidence of traffic violations using automatically detected context features
US11689787B1 (en) 2022-11-16 2023-06-27 Hayden Ai Technologies, Inc. Behind the windshield camera-based perception system for autonomous traffic violation detection
US11915499B1 (en) 2023-08-30 2024-02-27 Hayden Ai Technologies, Inc. Systems and methods for automated license plate recognition
US12142001B1 (en) 2023-12-28 2024-11-12 Hayden Ai Technologies, Inc. Systems and methods for determining a pose and motion of a carrier vehicle

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101837B1 (en) * 1995-01-24 2006-09-05 Martinex R & D Inc. Recombinant human alpha-fetoprotein as a cell proliferative agent
WO1996040866A1 (en) * 1995-06-07 1996-12-19 Novartis Ag Serum-free media for primitive hematopoietic cells and methods of use thereof
GB9828379D0 (en) * 1998-12-22 1999-02-17 Unilever Plc Skin care composition
US7439064B2 (en) * 2000-03-09 2008-10-21 Wicell Research Institute, Inc. Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium
GB0304799D0 (en) * 2003-03-03 2003-04-09 Glaxosmithkline Biolog Sa Novel method
WO2005070120A2 (en) * 2004-01-09 2005-08-04 Serologicals Investment Company, Inc. Cell culture media
GB2432835B (en) * 2004-09-08 2009-04-08 Wisconsin Alumni Res Found Culturing human embryonic stem cells
WO2006029197A1 (en) * 2004-09-08 2006-03-16 Wisconsin Alumni Research Foundation Medium and culture of embryonic stem cells

Also Published As

Publication number Publication date
EP2155859A1 (en) 2010-02-24
AU2008259726A1 (en) 2008-12-11
KR20100025569A (ko) 2010-03-09
WO2008148938A1 (en) 2008-12-11
US20100081200A1 (en) 2010-04-01
JP2010528642A (ja) 2010-08-26
CA2689321A1 (en) 2008-12-11
EP2155859A4 (en) 2010-06-30

Similar Documents

Publication Publication Date Title
FI20075417A0 (fi) Koostumuksia ja menetelmiä alkion kantasolujen kasvatukseen
FI20096288A0 (fi) Formulations and methods for culturing stem cells
DK3192865T3 (da) Enkelt pluripotent stamcelle-kultur
SE0950586L (sv) Förbättrad odling av stamceller
DK2574677T3 (da) Fremgangsmåder til celledyrkning
PL2634242T3 (pl) Ulepszony sposób hodowli komórek
DK2522717T3 (da) Oligopeptid-frie cellekulturmedier
IL254144A0 (en) Methods for reprogramming cells and uses thereof
ZA201606403B (en) Pluripotent stem cell culture on micro-carriers
DK2185693T3 (da) Differentiering af humane embryoniske stamceller
SI2459702T1 (sl) Gojišče celične kulture za izražanje adamts proteina
PL2240572T3 (pl) Wykorzystanie rna dla przeprogramowania komórek somatycznych
PL2046946T3 (pl) Hodowla pluripotencjalnych komórek macierzystych
BRPI0716762A2 (pt) melhorias da cultura celular
FI20106121A7 (fi) Soluviljelymateriaali
BR112013001089A2 (pt) composição de meio de cultura e método para cultivar células tronco mesenquimais derivadas de âmnio
DK2614141T3 (da) Hidtil ukendte fremgangsmåder og dyrkningsmedier til dyrkning af pluripotente stamceller
BRPI1011127A2 (pt) métodos para o cultivo de células tronco e células progenitoras
EP2401361A4 (en) METHOD AND COMPOSITIONS FOR STEM CELL CULTURES
HRP20182165T1 (hr) Postupak proizvodnje polipeptida ili virusa od interesa u kontinuiranoj staničnoj kulturi
DK3399019T3 (da) Fremgangsmåder til bevaring af kulturs levedygtighed
DE602007008627D1 (de) Zellkulturmedium
IT1394412B1 (it) Procedimento per l'essiccazione di biomassa algale
EP2531593A4 (en) PROCESS FOR THE ISOLATION AND CULTIVATION OF MESENCHYMAL STEM CELLS
EP2271739A4 (en) PRODUCT FOR CELL CULTURE